Clinical Trials on Breast Neoplasms in Netherlands

Total 3886 results

Leiden University
The Netherlands Cancer Institute; Dutch Cancer Society

Completed

Communication in Breast Cancer Care

Quality of Life | Breast Cancer | Communication

Netherlands
The Netherlands Cancer Institute
AstraZeneca

Suspended

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Breast Cancer

Netherlands
University Medical Center Groningen
The Netherlands Cancer Institute

Completed

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

Breast Cancer Female

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Terminated

AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (GELATO)

Breast Cancer

Netherlands
UMC Utrecht

Unknown

The MONET - Study: MR Mammography of Nonpalpable Breast Tumors (MONET)

Breast Neoplasms

Netherlands
University Medical Center Groningen

Terminated

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

High-Risk Breast Cancer

Netherlands
University College, London
European Union

Completed

PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional (PICTURE XS)

Early-Stage Breast Carcinoma

United Kingdom, Netherlands, Portugal
Menssana Research, Inc.
University of Erlangen-Nürnberg; Zuyderland Medical Centre; Mount Vernon Cancer...

Not yet recruiting

Breath Test to Predict Breast Cancer and Outcome of Mammography

Breast Cancer | Abnormal Mammogram, Unspecified

Netherlands, Germany, United Kingdom
Laurence J.C. van Warmerdam
Sanofi; Cephalon

Terminated

Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer (MYOHERTAX)

Breast Cancer | Neoplasm Metastasis

Netherlands
The Netherlands Cancer Institute
Maarten van de Weijden Foundation

Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (COSMO)

Oligoprogressive | Metastatic Cancer | Breast Cancer Invasive

Netherlands
Maastricht University

Completed

Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment. (BRASA)

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
The Netherlands Cancer Institute

Completed

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer (REVIVAL)

Breast Cancer | Ovarian Cancer | Advanced Cancer

Netherlands
European Organisation for Research and Treatment...

Completed

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Breast Cancer

Belgium, Netherlands, France
Institut de Radioprotection et de Surete Nucleaire
Institut Català d'Oncologia; Technical University of Munich; Hospital de Santa... and other collaborators

Completed

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY-HEART)

Breast Cancer Female

Spain, Germany, France, Netherlands, Portugal
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Metastatic Breast Cancer | Metastatic Triple Negative Breast Cancer

Japan, Belgium, France, Netherlands
UMC Utrecht

Completed

"The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-guided Localization' (WGL) in Breast Conserving Surgery for Non-palpable Breast Cancer: a Randomized Clinical Trial" (ROLL)

Breast Cancer

Netherlands
Jules Bordet Institute
Roche Pharma AG

Active, not recruiting

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 (ZEPHIR)

HER-2 Positive Breast Cancer

Belgium, Netherlands
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
Amsterdam UMC, location VUmc
Novartis; Borstkanker Onderzoek Groep

Unknown

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Metastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast

Netherlands
Radboud University Medical Center

Unknown

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Breast Neoplasms | Rectal Neoplasms

Netherlands
Life Molecular Imaging SA

Completed

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Diagnostic Imaging

Netherlands, Switzerland
Leiden University Medical Center

Active, not recruiting

Reducing Dexamethasone Around Docetaxel Infusion (REDEX)

Breast Cancer | Prostate Cancer

Netherlands
University Medical Center Groningen
Pink Ribbon Inc.

Completed

Evaluation of a Physical Activity Program in Overweight Breast Cancer Patients (I-Move)

Breast Cancer

Netherlands
University College, London
European Union

Completed

PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal (PICTURE L)

Breast Neoplasms

United Kingdom, Netherlands, Portugal
The Netherlands Cancer Institute
Universitaire Ziekenhuizen KU Leuven

Recruiting

Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients (HoLiBreast)

Breast Cancer | Liver Metastases

Netherlands, Belgium
The Netherlands Cancer Institute
Roche Pharma AG

Completed

Carboplatin-cyclophosphamide Combined With Atezolizumab (PROLOG)

Breast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial Cancer

Netherlands
European Organisation for Research and Treatment...

Terminated

Dissecting the Pathways of Therapy Resistance in Early Breast Cancer (MINDACTRelapse)

Breast Cancer

Belgium, Netherlands
Erasmus Medical Center

Active, not recruiting

Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis (CYSTATINcDK4/6)

Advanced Breast Cancer

Netherlands
Maastricht University Medical Center

Terminated

Prediction of Pain After Breast Cancer Surgery With EEG

Breast Cancer | Chronic Pain | Postoperative Pain

Netherlands
University Medical Center Groningen

Completed

Breast Cancer Long-term Outcome of Cardiac Dysfunction (BLOC)

Breast Neoplasms

Netherlands
Leiden University Medical Center
The Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaborators

Suspended

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer (DIRECT-2)

HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response Rate

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center; Maastricht University

Recruiting

Developing Breast (Cancer) Organoids

Breast Cancer

Netherlands
University Medical Center Groningen

Completed

Palbociclib and FES PET

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Preoperative Breast Irradiation (PROBI)

Breast Cancer

Netherlands
Amsterdam UMC, location VUmc
Borstkanker Onderzoek Groep; Comprehensive Cancer Centre The Netherlands; Dutch...

Recruiting

Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer (RT-HYPE)

Breast Cancer | Hyperthermia | Locoregional Recurrence | Re-irradiation

Netherlands
UMC Utrecht
Bayer; Maastricht University Medical Center; Amsterdam UMC, location VUmc; The... and other collaborators

Active, not recruiting

Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

Breast Cancer

Netherlands
Amsterdam UMC, location VUmc

Completed

Optimization of Systemic Treatment Strategies in Elderly Patients With Advanced Solid Malignancies (OptiMal)

Colorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced Malignancies

Netherlands
Maastricht University Medical Center

Completed

Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?

Breast Cancer

Netherlands
Borstkanker Onderzoek Groep
Amgen

Withdrawn

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer (PERIDENO)

Breast Neoplasms

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (Subito)

Breast Cancer

Netherlands, France
UMC Utrecht
Alexander Monro Hospital, Bilthoven; Amsterdam UMC; Cancer Center Amsterdam grant...

Recruiting

Breast Reconstruction and Neoadjuvant Radiotherapy (BRENAR)

Breast Cancer

Netherlands
Maastricht University Medical Center

Completed

Sensory Nerve Coaptation in DIEP Flap Breast Reconstruction

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Prospective Pilot Study ANDPrecise (ANDPrecise)

Breast Cancer

Netherlands
Catharina Ziekenhuis Eindhoven
Sanofi; Cephalon

Completed

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer (MYOTAX)

Breast Cancer | Neoplasm Metastasis

Netherlands
G1 Therapeutics, Inc.

Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female

United States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
Sanofi

Terminated

Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

Spain, Belgium, Italy, Czechia, Netherlands
Maastricht Radiation Oncology
The Netherlands Cancer Institute; Diakonessenhuis, Utrecht

Completed

Radiotherapy After Primary Chemotherapy for Breastcancer (RAPCHEM)

Breast Cancer

Netherlands
GlaxoSmithKline

Completed

A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients

Neoplasms, Breast

United States, Netherlands, Canada
Maastricht University Medical Center

Completed

Nerve Coaptation in LTP Flap Breast Reconstruction

Breast Cancer

Netherlands

Clinical Trials on Breast Neoplasms in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations